Technetium (99mTc) arcitumomab

Technetium (99mTc) Arcitumomab

Technetium (99mTc) arcitumomab

to get instant updates about 'Technetium (99mTc) Arcitumomab' on your MyPage. Meet other similar minded people. Its Free!


All Updates

Technetium (<sup>99m</sup>Tc) arcitumomab is a drug used for the diagnostic imaging of colorectal cancers, marketed by Immunomedics. It consists of the Fab' fragment of a monoclonal antibody (arcitumomab, trade name CEA-Scan) and a radionuclide, technetium-99m.


Technetium (<sup>99m</sup>Tc) arcitumomab is an immunoconjugate. Arcitumomab is a Fab' fragment of IMMU-4, a murine IgG1 monoclonal antibody extracted from the ascites of mice. The enzyme pepsin cleaves the F(ab')<sub>2</sub> fragment off the antibody. From this, the Fab' fragment is prepared by mild reduction.

Before application, arcitumomab is reconstituted with a solution of the radioactive agent sodium pertechnetate (<sup>99m</sup>Tc) from a technetium generator.

Mechanism of action

Arcitumomab recognizes carcinoembryonic antigen (CEA), an antigen over-expressed in 95% of colorectal cancers. Consequently, the antibody accumulates in such tumours together with the radioisotope, which emits photons. Via single photon emission computed tomography (SPECT), high-resolution images showing localisation, remission or progression, and metastases of the tumour can be obtained.


Technetium (<sup>99m</sup>Tc) arcitumomab is contraindicated for patients with known allergies or...
Read More

No feeds found

Posting your question. Please wait!...

No updates available.
No messages found
Suggested Pages
Tell your friends >
about this page
 Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
 Find your friends
  Find friends on MyPage from